298 related articles for article (PubMed ID: 24449771)
1. Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens.
Goneau LW; Yeoh NS; MacDonald KW; Cadieux PA; Burton JP; Razvi H; Reid G
Antimicrob Agents Chemother; 2014; 58(4):2089-97. PubMed ID: 24449771
[TBL] [Abstract][Full Text] [Related]
2. Persister Escherichia coli Cells Have a Lower Intracellular pH than Susceptible Cells but Maintain Their pH in Response to Antibiotic Treatment.
Goode O; Smith A; Zarkan A; Cama J; Invergo BM; Belgami D; Caño-Muñiz S; Metz J; O'Neill P; Jeffries A; Norville IH; David J; Summers D; Pagliara S
mBio; 2021 Aug; 12(4):e0090921. PubMed ID: 34281389
[TBL] [Abstract][Full Text] [Related]
3. Role of oxidative stress in persister tolerance.
Wu Y; Vulić M; Keren I; Lewis K
Antimicrob Agents Chemother; 2012 Sep; 56(9):4922-6. PubMed ID: 22777047
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli.
Hofsteenge N; van Nimwegen E; Silander OK
BMC Microbiol; 2013 Feb; 13():25. PubMed ID: 23379956
[TBL] [Abstract][Full Text] [Related]
5. The Role of Integration Host Factor in Escherichia coli Persister Formation.
Nicolau SE; Lewis K
mBio; 2022 Feb; 13(1):e0342021. PubMed ID: 34982597
[TBL] [Abstract][Full Text] [Related]
6. Specific Enrichment and Proteomics Analysis of Escherichia coli Persisters from Rifampin Pretreatment.
Sulaiman JE; Hao C; Lam H
J Proteome Res; 2018 Nov; 17(11):3984-3996. PubMed ID: 30336045
[TBL] [Abstract][Full Text] [Related]
7. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells.
Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K
mBio; 2017 Dec; 8(6):. PubMed ID: 29233898
[TBL] [Abstract][Full Text] [Related]
8. Proteomic Investigation of Tolerant
Sulaiman JE; Lam H
J Proteome Res; 2020 Feb; 19(2):900-913. PubMed ID: 31920087
[TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli.
Dörr T; Vulić M; Lewis K
PLoS Biol; 2010 Feb; 8(2):e1000317. PubMed ID: 20186264
[TBL] [Abstract][Full Text] [Related]
10. Genetic basis of persister tolerance to aminoglycosides in Escherichia coli.
Shan Y; Lazinski D; Rowe S; Camilli A; Lewis K
mBio; 2015 Apr; 6(2):. PubMed ID: 25852159
[TBL] [Abstract][Full Text] [Related]
11. Persister Heterogeneity Arising from a Single Metabolic Stress.
Amato SM; Brynildsen MP
Curr Biol; 2015 Aug; 25(16):2090-8. PubMed ID: 26255847
[TBL] [Abstract][Full Text] [Related]
12. Growth arrest or drug target inactivity is not sufficient for persister formation in E. coli.
Xu Y; Cui P; Zhang Y; Zhang W
Discov Med; 2020; 29(157):103-112. PubMed ID: 33002406
[TBL] [Abstract][Full Text] [Related]
13. The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy.
Jõers A; Kaldalu N; Tenson T
J Bacteriol; 2010 Jul; 192(13):3379-84. PubMed ID: 20435730
[TBL] [Abstract][Full Text] [Related]
14. SOS response induces persistence to fluoroquinolones in Escherichia coli.
Dörr T; Lewis K; Vulić M
PLoS Genet; 2009 Dec; 5(12):e1000760. PubMed ID: 20011100
[TBL] [Abstract][Full Text] [Related]
15. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli.
Keren I; Shah D; Spoering A; Kaldalu N; Lewis K
J Bacteriol; 2004 Dec; 186(24):8172-80. PubMed ID: 15576765
[TBL] [Abstract][Full Text] [Related]
16. Multidrug tolerance of biofilms and persister cells.
Lewis K
Curr Top Microbiol Immunol; 2008; 322():107-31. PubMed ID: 18453274
[TBL] [Abstract][Full Text] [Related]
17. A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.
Cameron DR; Shan Y; Zalis EA; Isabella V; Lewis K
J Bacteriol; 2018 Sep; 200(17):. PubMed ID: 29941425
[TBL] [Abstract][Full Text] [Related]
18. Flow-cytometry analysis reveals persister resuscitation characteristics.
Mohiuddin SG; Kavousi P; Orman MA
BMC Microbiol; 2020 Jul; 20(1):202. PubMed ID: 32640993
[TBL] [Abstract][Full Text] [Related]
19. Rapid Freezing Enables Aminoglycosides To Eradicate Bacterial Persisters via Enhancing Mechanosensitive Channel MscL-Mediated Antibiotic Uptake.
Zhao Y; Lv B; Sun F; Liu J; Wang Y; Gao Y; Qi F; Chang Z; Fu X
mBio; 2020 Feb; 11(1):. PubMed ID: 32047133
[TBL] [Abstract][Full Text] [Related]
20. PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
Li Y; Zhang Y
Antimicrob Agents Chemother; 2007 Jun; 51(6):2092-9. PubMed ID: 17420206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
